What Gabrielle Union's Women's HRT Protocol Would Cost Outside a Celebrity Context

Prescription access and medication affordability image for What Gabrielle Union's Women's HRT Protocol Would Cost Outside a Celebrity Context

At a glance

  • Public confirmation: Union has discussed fertility struggles, IVF, surrogacy, and perimenopause symptoms in multiple interviews
  • Drug class: Estrogen and progesterone formulations used across fertility treatment and menopausal hormone therapy (MHT)
  • Monthly cost range (maintenance HRT): $4 to $250+ depending on formulation and insurance status
  • IVF cycle cost: $12,000 to $25,000+ per cycle, with hormonal medications adding $3,000 to $7,000
  • Insurance reality: 21 states mandate some IVF coverage; perimenopause HRT coverage varies widely by plan

What Gabrielle Union Has Said Publicly

Gabrielle Union has been unusually candid about her reproductive health journey. In her 2017 memoir We're Going to Need More Wine and in interviews with outlets including People and Today, Union confirmed she experienced "eight or nine" failed IVF cycles before she and Dwyane Wade welcomed their daughter Kaavia via surrogate in 2018. She has described the hormonal injections, the emotional toll of repeated cycles, and the physical side effects she endured.

More recently, Union has spoken about entering perimenopause in her late 40s, describing symptoms including mood changes, irregular cycles, and sleep disruption. She has discussed working with her medical team to manage these symptoms, though she has not publicly specified the exact medications or doses she currently uses for perimenopause management.

The HealthRX Medical Team notes an important distinction here: Union's IVF-related hormone use is confirmed and well-documented through her own public statements. Her current perimenopause treatment specifics remain private. What follows is a clinical cost analysis based on the standard protocols a patient in Union's described situation would typically encounter.

The Two Phases of Hormone Therapy in Union's Public Story

Union's public timeline maps onto two distinct clinical scenarios that carry very different cost profiles.

Phase one: fertility treatment hormones. IVF protocols typically involve gonadotropins (injectable FSH and LH analogs like follitropin alfa), GnRH agonists or antagonists to prevent premature ovulation, trigger shots (hCG or GnRH agonist), and luteal-phase progesterone support. These medications are used in high doses for short, intensive periods. A single IVF stimulation cycle requires daily injections over 8 to 14 days, with doses adjusted based on follicular response monitored via ultrasound and bloodwork.

Phase two: perimenopause management. Standard menopausal hormone therapy for someone in Union's described demographic (late 40s, symptomatic) typically involves systemic estradiol combined with a progestogen for endometrial protection. The 2022 Hormone Therapy Position Statement from the North American Menopause Society supports initiation of HRT in symptomatic women under 60 or within 10 years of menopause onset, with benefits generally outweighing risks in this window.

These two phases carry fundamentally different price tags.

What IVF Hormones Actually Cost Without Celebrity Resources

The fertility medication component of IVF is where costs hit hardest. Based on 2025 pharmacy pricing data:

| Medication | Role in IVF | Typical cycle cost | |---|---|---| | Follitropin alfa (Gonal-F) | Ovarian stimulation | $3,000 to $5,000 | | Menotropins (Menopur) | Ovarian stimulation | $2,000 to $4,000 | | Cetrotide or Ganirelix | Prevent premature ovulation | $250 to $900 | | hCG trigger (Ovidrel) | Final egg maturation | $100 to $250 | | Progesterone in oil (injectable) | Luteal support | $50 to $200 | | Endometrin (vaginal progesterone) | Luteal support | $300 to $700 |

Total medication costs per IVF cycle typically land between $3,000 and $7,000. The American Society for Reproductive Medicine estimates total per-cycle costs (including monitoring, retrieval, lab fees, and medications) at $12,000 to $17,000 on average, though many clinics charge $20,000 or more.

Union has publicly stated she went through eight or nine cycles. At average pricing, that represents $96,000 to $153 to 000 in IVF costs alone, before accounting for the surrogacy arrangement that ultimately resulted in Kaavia's birth. Gestational surrogacy adds $100,000 to $200 to 000 in agency fees, legal costs, surrogate compensation, and medical expenses.

Insurance Coverage for Fertility Treatment: A State-by-State Problem

As of 2025, 21 states have laws requiring some form of fertility treatment insurance coverage, but the specifics vary enormously. Some mandates require insurers to "cover" IVF; others only require them to "offer" coverage as an optional rider. Lifetime caps, cycle limits, age restrictions, and marital status requirements create a patchwork that leaves many patients paying entirely out of pocket.

California, where Union resides, does not mandate IVF coverage specifically (California's mandate covers fertility diagnosis but excludes IVF). Illinois, Massachusetts, and Connecticut have among the strongest mandates. For a patient without employer-sponsored fertility benefits, the financial burden of Union's described IVF journey would be catastrophic without significant personal resources.

The HealthRX Medical Team observes that this coverage gap creates a two-tier system. Patients with Union's financial resources can pursue eight or nine IVF cycles. Most patients cannot afford more than one or two without coverage, regardless of clinical indication. Research published in Fertility and Sterility demonstrates that insurance mandates significantly increase IVF utilization rates, suggesting suppressed demand driven by cost rather than clinical need.

Perimenopause HRT: Far More Affordable, Still Not Simple

The cost picture for perimenopause hormone therapy is dramatically different from fertility treatment. Generic formulations of the core medications are inexpensive:

  • Oral estradiol (1 to 2 mg daily): $4 to $15/month with GoodRx or similar discount programs
  • Estradiol patch (0.025 to 0.1 mg, twice weekly): $15 to $80/month depending on brand vs. generic
  • Micronized progesterone (Prometrium, 100 to 200 mg): $10 to $30/month generic; $80 to $150 brand
  • Combination patch (Combipatch): $120 to $250/month, limited generic availability
  • Vaginal estrogen (Vagifem, Estrace cream): $25 to $200/month depending on formulation

For a patient on a standard transdermal estradiol patch plus oral micronized progesterone regimen, which the Endocrine Society's 2015 clinical practice guideline supports, monthly out-of-pocket costs with generic medications and a discount card can be as low as $20 to $40.

Insurance coverage for menopausal HRT is generally better than for fertility treatment, but not guaranteed. Some plans classify HRT as "preventive" (particularly after the WHI follow-up data clarified the benefit-risk profile for younger postmenopausal women), while others require prior authorization or apply specialty-tier copays to branded formulations.

The Hidden Costs Beyond the Prescription

Prescription price is only part of the access equation. A patient pursuing HRT for perimenopause also faces:

Provider access. Finding a clinician who is current on menopause management can be difficult. A 2023 survey found that the majority of OB-GYN residency programs provide minimal menopause-specific training. Many patients report being told they are "too young" for perimenopause in their mid-40s or being offered antidepressants instead of hormones.

Lab monitoring. Initial hormone panels (FSH, estradiol, thyroid function, lipid panel) and follow-up labs add $200 to $500 per year without insurance. Some plans cover these as part of preventive care; others do not.

Specialist visits. An initial consultation with a menopause specialist ranges from $250 to $500 out of pocket. Follow-up visits cost $150 to $300. Union has the resources to see whichever specialist she chooses. A patient on a high-deductible health plan may delay care because of visit costs alone.

The HealthRX Medical Team Take

Union's public transparency about both her fertility journey and her perimenopause experience serves a genuine clinical information function. She has helped normalize conversations that many women still find difficult to initiate with their own physicians.

The cost and access reality, though, is stark. The fertility treatment phase of Union's described experience represents a financial commitment that excludes the vast majority of American patients. Even at the lower end of estimates, eight IVF cycles would cost $96 to 000 in medications and procedures alone. Without state-mandated insurance coverage or significant personal wealth, this volume of treatment is simply inaccessible.

Perimenopause HRT, by contrast, is one of the more affordable long-term prescription regimens available. The clinical challenge is not primarily cost but rather provider education and willingness to prescribe. Generic estradiol and progesterone are on the $4 formulary lists at major pharmacy chains. The barrier is getting the prescription in the first place.

For patients following Union's story and considering their own options, the HealthRX Medical Team recommends: confirm whether your state mandates fertility treatment coverage before assuming you will pay out of pocket; use the NAMS "Find a Menopause Practitioner" tool to locate a certified provider; and recognize that generic HRT formulations are clinically equivalent to branded products in the vast majority of cases, per FDA bioequivalence standards.

Frequently asked questions

References